SCHEMBL7947463

SCHEMBL7947463

N#Cc1ccc(COc2ccc(N3CCN(c4ccncc4)CC3)cc2)cc1

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 4/20 0.61
HRH1 P35367 3/20 0.61
MAOB P27338 1/20 0.51
KDM4E B2RXH2 2/20 0.48
TP53 P04637 1/20 0.48
CYP4F2 P78329 1/20 0.45
CYP4A11 Q02928 1/20 0.45
ITGB3 P05106 1/20 0.45
ITGA2B P08514 1/20 0.45
PRKDC P78527 2/20 0.45
RAB9A P51151 1/20 0.45
LMNA P02545 1/20 0.45
MAPT P10636 1/20 0.45
TSHR P16473 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.43
HRH2 P25021 1/20 0.43
CYP19A1 P11511 1/20 0.43
CYP11B1 P15538 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7954928 0.84 HRH1 (0.61) HRH3HRH1KDM4ETP53ITGB3
SCHEMBL7956560 0.84 KDM4E (0.65) HRH3HRH1KDM4ETP53SMN1; SMN2
SCHEMBL7958205 0.83 F10 (0.53) HRH3HRH1MAOBITGB3ITGA2B
SCHEMBL7947461 0.83 HTR1A (0.50) HRH3HRH1MAOBKDM4ETP53
SCHEMBL9127449 0.80 MAOB (0.60) HRH3MAOBCYP4F2CYP4A11RAB9A
SCHEMBL4676367 0.79 ADRB2 (0.60)
SCHEMBL7958273 0.79 HRH1 (0.58) HRH3HRH1KDM4ETP53SMN1; SMN2
SCHEMBL8567186 0.78 HRH3 (0.52) HRH3HRH1MAOBKDM4EITGB3
SCHEMBL4676358 0.77 ITGB3 (0.43) HRH3HRH1KDM4EITGB3ITGA2B
SCHEMBL29741480 0.77 MAOB (0.81) HRH3MAOBCYP4F2CYP4A11RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6313127-B1 FOR THERAPY OF HYPERCHOLESTEROLEMIA OR ATHEROSCLEROSIS ZENECA LIMITED (GB) 2001-11-06 US disclosed